NCT04164069 2024-12-27Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabOhio State University Comprehensive Cancer CenterPhase 1 Completed9 enrolled
NCT01007552 2017-03-29A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile DuctsRoswell Park Cancer InstitutePhase 2 Completed50 enrolled 12 charts
NCT00356889 2014-05-28Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary TumorsNational Cancer Institute (NCI)Phase 2 Completed56 enrolled 9 charts
NCT00350753 2009-07-15Avastin and Tarceva for Upper Gastrointestinal CancersRigshospitalet, DenmarkPhase 2 Completed126 enrolled